Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chart: FDA Recalls & Court Actions

This article was originally published in The Tan Sheet

Executive Summary

FDA Recalls & Court Actions



FDA Recalls & Court Actions

Dec. 5, 2001

CLASS II

Equate Allergy Medication Decongestant Caplets

In 24 caplet blister cartons. The product is an OTC product containing Diphenhydramine Hydrochloride 25 mg and Pseudoephedrine Hydrochloride 60 mg, capsule-shaped tablets. Lot No. 1GB0825, 1GB1041, 1GB1042.

Manufacturer:

Leiner Health Products, Inc. Carson, CA.

Recalled by:

Leiner Health Products, Inc. Fort Mill, SC. Firm initiated recall is ongoing.

Distribution:

Nationwide; 45,504/24 caplet cartons.

Reason:

Misbranding; directions for use may lead to a doubling of the dosage.

Recall number:

D-040-2.

EDITORS' NOTE: Tabulation prepared from information provided by FDA. The agency has three classes of recalls. Class I - violative product poses reasonable probability of serious adverse health consequences or death; Class II - violative product may cause temporary or medically reversible adverse health consequences; probability of serious consequences remote; Class III - violative product not likely to cause adverse health consequences. Editors of "The Tan Sheet" appreciate hearing from any company that would like to provide additional information on any recall listed in a weekly tabulation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel